The invasion and intracellular survival ofBordeteUla bronchiseptica in mouse dendritic cells were investigated. The results obtained suggest that B. bronchiseptica binds specifically to glycosylated receptors present on the plasma membrane of dendritic cells, thereby inducing a signal that triggers an actin polymerization-dependent phagocytic process, probably via a protein kinase-dependent transducing phosphorylation signal. The energy required for the uptake process by host cells is provided mainly by the glycolytic pathway. An intact microtubule system and de novo protein synthesis in eukaryotic and prokaryotic cells are essential for efficient uptake and intracellular survival. The interaction of B. bronchiseptica with dendritic cells may be pertinent to natural infections that follow a chronic clinical course and predispose to secondary infections, and to the T-cell response involved in protective immunity following infections caused by Bordetella spp.
Bordetella bronchiseptica is associated with different pathological syndromes characterized mainly by a mild and chronic clinical course in several animal species (21, 34, 59) . Traditionally, the toxins and adhesins produced by these microorganisms were considered the main factors involved in pathogenesis of Bordetella spp. (3, 21, 23, 27, 34, 47, 59) , although an increasing body of evidence supports a general invasive capability for B. bronchiseptica (50, 51) and other Bordetella spp. (5, 8, 11, 13, 17, 33, 46, 49) . Particularly significant in the pathogenesis of Bordetella pertussis appear to be invasion and intracellular survival in macrophages (8, 17, 49) .
We have recently reported that B. bronchiseptica is efficiently internalized by mouse dendritic cells (DC) and survives intracellularly for at least 72 h (25) . The interaction with DC could be relevant in the infective processes caused by B. bronchiseptica since DC are present in the airways (38, 53) , the portal of entry for B. bronchiseptica, and are the most efficient antigenpresenting cells (57, 58) . This interaction might explain, at least in part, the chronic clinical course of the disease, the secondary infections that commonly occur, and the type of immune response elicited during natural infection. In the present study, a fully functional murine spleen DC line was used to characterize the mechanisms of bacterial uptake and persistent intracellular survival.
MATERIALS AND METHODS
Bacterial strains and media. The wild-type B. bronchiseptica 5376 was used throughout this work (60) and cultivated at 37°C on Bordet-Gengou agar base (Difco Laboratories, Detroit, Mich.) supplemented with 1% glycerol and 15% (vol/vol) defibrinated horse blood, in SS broth (54) , and in brain heart infusion broth or agar (Difco Laboratories 50 ,M), cytochalasin D (CD; 0.5 ,ug ml-l), nocodazole (3 ,ug ml-'), mitomycin (40 ,ug ml-'), sodium fluoride (NaF; 20 mM), iodoacetic acid (0.2 mM), 2,4-dinitrophenol (2 mM), heparin (100 U ml-'), DEAE dextran (DEAED; 30 jxg ml-'), tunicamycin (1 ,ug ml-'), neuraminidase type V from Clostridiumperfringens (0.1 U ml-'), actinomycin D (AD; 1 ,ug ml-'), chloramphenicol (50 ,ug ml-'), staurosporine (1 ,uM) , genistein (200 FM), calphostin C (0.35 ,uM), phorbol 12-myristate 13-acetate (PMA; 4 ,uM), NH4Cl (10 mM), chloroquine (10 ,ug ml-'), the lipid-soluble cyclic AMP (cAMP) derivative N6,2'-O-dibutyryladenosine 3':5'-cyclic monophosphate monosodium salt (cAMPd; 2 mM), the calcium ionophore A23187 (1 ,uM) , concanavalin A (1 ,ug ml-'), recombinant tumor necrosis factor (Genzyme Corp., Cambridge, Mass.; 100 U ml-1), lipopolysaccharide from Escherichia coli 026:B6 (0.5 ng ml-'), recombinant murine gamma interferon (IFN--y) (Genzyme Corp.; 20 U ml-'), granulocyte-macrophage colony-stimulating factor (GM-CSF) (Genzyme Corp.; 500 ml-1), a synthetic peptide containing the RGD sequence present in filamentous hemagglutinin (FHA; GNVTVGRGD PHQGVL, RGD-pep; 10 ,ug ml-'), a control peptide containing FHA sequences located downstream of the RGD region (PHQGVLAQGDIIMDA, cont-pep; 10 p,g ml-'), galactose (50 mM), and rabbit polyclonal antibodies raised against the FHA or the outer membrane protein pertactin (1:100 dilution).
Inhibition experiments were also performed with the following antibodies specific for surface proteins and receptors of DC, together with negative-control antibodies specific for markers absent in DC: monoclonal antibody (MAb) against Thy-1 (clone ATCC HB23), MAb against FAll (from R. M. Steinman), MAb against MAC-2 (clone ATCC TIB166), MAb against CD11a (clone ATCC TIB213), MAb against FcyRII (clone ATCC HB197), MAb against F4/80 (clone ATCC HB198), MAb against CD11b (clone ATCC TIB128), MAb against ICAM-1 (clone ATCC CRL1878), and MAb against CD11c (clone ATCC HB224).
Cells were pretreated for 1 h before addition of bacteria and throughout the invasion assays, except when the following compounds were used: PMA that was used for short-term (30-min) and long-term (24-h) pretreatments; IFN--y, GM-CSF, and lipopolysaccharide (24 h before and throughout the experiment); and DEAED (two washes before infection). The hybridoma supernatants containing MAb specific for surface proteins were used at a 1:4 dilution to pretreat DC for 2 h. All compounds for which there is no specific information were provided by Sigma Chemie GmbH. The concentration of the inhibitor used was selected on the basis of data obtained in preliminary experiments, using values reported in the literature for several cell systems (2, 11, 12, 17, 19, 24, 26, 29, 32, 33, 39, 41, 48, 62) ; when possible the activity of the inhibitor was established by using control bacteria (e.g., inhibition by CD of Listeria monocytogenes uptake) or assessing the biological activity (e.g., pH of the intracellular compartment by using acridine orange after pretreatment with chloroquine or NH4Cl; staining of the microtubules after pretreatment with nocodazol). Treatments of bacteria and DC with the different compounds did not significantly reduce cell viability (data not shown).
Scanning electron microscopy. Infected cells on round 13-mm Thermanox coverslips (Inter Med NUNC) were fixed in a PBS solution containing 3% glutaraldehyde and 5% formaldehyde for 45 min on ice, washed with PBS, dehydrated in a graded series of acetone concentrations, and subjected to critical-point drying with CO2. The (Fig. 1) . We cannot exclude the possibility that the strong effect of CD is due in part to the major morphologic alterations also produced, which might reduce bacterial attachment ( Fig. 2C and D) , although bacteria seemed to attach efficiently to CD-treated cells ( Fig.  2C and D) . Moreover difference in the mean number of bacteria recovered from untreated and pretreated DC after 30 min and 1 and 2 h of interaction at 4°C was not statistically significant (P . 0.05). Bacteria preferentially attached to the cell periphery, as can best be seen in CD-treated cells with a flat shape (Fig. 2C and  D) .
Role of the microtubule system. The movement of cytoplasmic organelles is mediated by both microfilaments and microtubules (1, 36) , which are also central structural components of the cell framework. The role of the microtubule system in the uptake process was analyzed by inhibiting microtubule polymerization with nocodazole: this resulted in an 86% inhibition (Fig. 1) . This effect may be due to the very complex microtubule network in DC, which may be essential for their highly specialized functions, or to microtubule involvement in some step(s) of the microfilamentdependent phagocytosis. Alternatively, B. bronchiseptica may be taken up by a second microtubule-dependent endocytic pathway. This possibility is not unlikely, given that a similar mechanism, which coexists with the classical microfilamentdependent pathway, has been recently demonstrated for some strains of Campylobacter jejuni and Citrobacter freundii (39) . Moreover, an intact microtubule network was reported to be essential for maintenance of Salmonella-induced filaments which are correlated with intracellular bacterial replication (19) .
To assess whether the effect of nocadozole might be due in part to inhibition of the mitotic process, which also involves microtubules, cells were pretreated with mitomycin, an inhibitor of DNA synthesis and nuclear division. The slightly smaller number of viable microorganisms recovered suggested that the effect of blocking cell division is very weak or insignificant (Fig.   1 ).
Source of energy for the uptake process. Endocytic processes require energy that is generated in host cells by glycolytic or oxidative metabolic pathways (26) . To assess the contribution of these two potential pathways, cells were pretreated with iodoacetic acid or NaF, which block the glycolytic route, or with 2,4-dinitrophenol, which impairs the oxidative pathway. The 95, 92, and 25% reduction in the number of CFU observed after pretreatment with iodoacetic acid, NaF, and 2,4-dinitrophenol, respectively, suggests that DC derive the energy for uptake of B. bronchiseptica mainly from glycolysis.
Specific versus nonspecific binding. It has been reported that polyanions or polycations may affect infection rates of eukaryotic cells by modifying the cytoplasmic membrane and impairing nonspecific binding (32) . To study the role of nonspecific electrostatic interactions in the attachment of B. bronchiseptica to DC, cells were treated with heparin and DEAED. The 15 and 30% inhibition in uptake observed after heparin and DEAED pretreatment, respectively (Fig. 1) , suggests that electrostatic interactions play a minor role in the bacterial attachment that leads to invasion and that binding to a specific receptor(s) is the dominant mechanism involved. DC constitutively express on their surface high levels of adhesion and costimulatory molecules implicated in cell-cell adhesion and signaling (57 (16, 35, 39) .
Transduction signals involved in the uptake process. The results reported above suggest that attachment of B. bronchiseptica to DC surface receptors generates an uptake signal that triggers a microfilament-dependent internalization mechanism. Protein kinases (PK) are often involved in the transduction of signals generated by surface receptors (42) , using phosphorylation to activate other proteins that may in turn effect internalization, as has been described for other invasive microorganisms (18, 48) . PK are also involved in the regulation of surface receptors (e.g., integrins), adhesion, and cytoskeletal reorganization (30, 42) . To assess whether PK are involved in the uptake process, DC were treated with the wide-range PK inhibitor staurosporine, the protein kinase C (PKC) inhibitor calphostin C, and the tyrosine PK inhibitor genistein. The results obtained indicated that more than one PK is involved in the transduction mechanism or intracellular survival. The most severe reduction (83%) was obtained with inhibitors of tyrosine PK, but a significant reduction (54%) was also seen with the PKC inhibitor.
PMA has been shown to increase PKC levels during shortterm treatments but to lower them to calphostin C treatment levels during longer-term (overnight) treatments (12) . To further assess the role of PKC in the uptake process, DC were treated overnight with PMA; the intracellular survival of bacteria was reduced to an extent (43%) similar to that of calphostin C-treated cells (54%). This supports a role of PKC in the internalization process. Other invasive bacteria are readily phagocytized by cells pretreated with PK inhibitors (48), so the inhibitory effect seems to be specific for B. bronchiseptica (and perhaps DC) and not to be a general effect on phagocytosis. The activity of PK might result in part from effects on the microtubule system (see above), since microtubules are critically regulated by proteins whose activities are controlled by phosphorylation (24) . Intracellular survival of B. bronchiseptica. After internalization, B. bronchiseptica is able to survive intracellularly for at least 72 h (25) . In principle, invasive bacteria that do not escape from the phagosome can survive by several different mechanisms: inhibition of the respiratory burst, resistance to lysosomal enzymes, attenuation of phagosome acidification, inhibition of phagolysosome fusion, and/or targeting following endocytosis to an unfused compartment (2, 14-16). The first two mechanisms seem unlikely, since damaged bacteria were present within phagolysosomes 4 h after infection (25) and it has been previously demonstrated that the respiratory burst occurs at normal levels in polymorphonuclear cells infected with Bordetella spp. (55, 56) .
Ammonium chloride has been shown to inhibit the phagolysosome fusion process and to impair endosome acidification (22) , whereas chloroquine raises the pH of the intracellular compartment, thereby affecting proteolytic activity (4, 63) . Therefore, if the phagolysosome fusion or the phagosome acidification processes are unaffected by B. bronchiseptica, these compounds may improve bacterial survival. Conversely, acidification of the endocytic compartment might be necessary for bacterial survival, as has been demonstrated for Salmonella spp. and Coxiella bumetii (14, 19) . However, these compounds had no significant effect on bacterial survival (Fig. 1) , suggesting that B. bronchiseptica may impair the phagolysosome fusion and/or acidification and that this inhibition cannot be in- creased by other compounds. Such mechanisms for survival in the vacuolar nonpermissive environment have been proposed for Mycobacterium tuberculosis, Legionella pneumophila, Toxoplasma gondii, and Salmonella spp. (6, 14, 28) . Alternatively, B. bronchiseptica might be targeted to an unfused compartment, as has been demonstrated for M. tuberculosis (37) .
Short-term PMA treatment has been reported to impair the infectivity of intracellular pathogens by improvement of the metabolic burst, superoxide production, and phagolysosome fusion (12) . cAMP analogs also suppress infection of eukaryotic cells by invasive bacteria by mimicking the effect of high cAMP levels that favors the release of lysosomic enzymes inside phagosomes (9, 61) . The lack of effect after short-term pretreatment with PMA and cAMPd supports the hypothesis that B. bronchiseptica is targeted to a unfused compartment and is in agreement with electron microscopy results (25) .
Effect of DC activation. Nonspecific cell activators and stimulating factors, like ionophores, concanavalin A, and lipopolysaccharide impair the infectivity of invasive microorganisms and result in the production of cytokines, such as tumor necrosis factor, IFN-y, and GM-CSF (7, 10, 31, 41, 45) , involved in the inflammatory response to infectious microorganisms. These activators also enhance DC viability and/or function (57) , inducing the production of surface molecules and improving maturation. The anti-infective effect of these compounds could be due to an increase in the metabolic burst, phagolysosome fusion, phagocytosis, PKC, Ca' influx, or superoxide generation or to downregulation of transferrin receptor (43) . This prompted us to analyze the effect of DC activation by different compounds on bacterial intracellular survival. The results given in Fig. 3 show that while A23187, concanavalin A, and, particularly, tumor necrosis factor exhibited antibacterial activity (26, 19 , and 44% inhibition, respectively), lipopolysaccharide and IFN--y increased the number of viable intracellular bacteria (174 and 155% of the control). This suggested that either the production of new receptor molecules was induced (e.g., IFN--y induces posttranslational modifications) or DC became more active in endocytosis. GM-CSF displayed very little effect, if any at all (108% of the control).
Adhesins and receptors. FHA mediates adhesion to and invasion of macrophages by Bordetella spp. through interaction with the integrin complement receptor 3 via its RGD-containing domain and adhesion to other cells via a galactose-binding domain (33, 46, 49) . Therefore, the possible role of this adhesin in the interaction with DC was analyzed. No inhibition was obtained when RGD-pep and galactose were used (113 and 108% of the control, respectively), suggesting that neither the RGD sequence nor the galactose-binding domains of FHA are involved in the invasion of DC (Fig. 4) . A polyclonal antibody against FHA also failed to inhibit invasion, which tends to exclude other potential binding sites in FHA (Fig. 4) . These results are in agreement with the uptake and intracellular survival of the B. bronchiseptica bvg mutant that lacks FHA (25) .
The internalization of B. pertussis by mammalian cells might also be mediated by the RGD sequence present in outer membrane protein 69 (33) . However, pretreatment with antibodies against outer membrane protein did not impair uptake but resulted in an enhancement, as was seen with antibodies against FHA (Fig. 3) . This increase in the uptake could be due to the presence of agglutinating antibodies, which result in the formation of clumps that may be endocytosed more easily (Fig.  2G) . Alternatively, opsonized bacteria might bind to the few Fc,yRII receptors present in DC that could in turn have a minor role in either binding or internalization.
To identify the cellular receptors involved in the specific binding that leads to internalization, antibodies that recognize surface proteins synthesized by DC were used in inhibition experiments (Fig. 4) . Pretreatment with MAbs against the surface receptors MAC-2, CD11a, FcyRII, and F4/80, which are expressed at low or intermediate levels by DC (40, 57) , had no effect on internalization (109, 96, 119, and 96% of the control, respectively); MAb against CD1lb that is expressed at intermediate levels produced only 19% inhibition; whereas MAbs against ICAM-1 and CD11c that are expressed at high levels resulted in 38 and 46% inhibition, respectively (Fig. 4) . This could be explained either by the specific blocking of the receptor involved in the internalization or by a nonspecific masking of unknown surface structures implicated in the binding that leads to the uptake process. However, attachment rates were unaffected by treatment with MAbs against ICAM-1 and CDllc (Fig. 2F) . MAbs against Thy-1 (expressed only by T lymphocytes) and FA1l (DC endocytic vacuole component) were used as control antibodies and had no effect (Fig. 4) . Taken (44) .
